Literature DB >> 34377382

Craniofacial Morphology and Upper Airway Dimensions in Patients with Hypermobile Ehlers-Danlos Syndrome Compared to Healthy Controls.

Liselotte Sonnesen1, Tessie Pawlik1, Eva Fejerskov Lauridsen2.   

Abstract

OBJECTIVES: The aims of the present case-control study were to compare craniofacial morphology, airway minimum cross-sectional area and airway volume between patients with hypermobile Ehlers-Danlos syndrome and healthy controls.
MATERIAL AND METHODS: The sample comprised 18 hypermobile Ehlers-Danlos syndrome (hEDS) patients (16 females, 2 males, mean age 34.1 [SD 10.35] years), clinically diagnosed and genetically tested in order to exclude other types of EDS, and 16 controls (14 females, 2 males, mean age 37.9 [SD 10.87] years) with neutral occlusion and normal craniofacial morphology. Craniofacial morphology was assessed on lateral cephalograms. Minimum cross-sectional area and upper airway volume were assessed on cone-beam computed tomography and analysed by standard and well-validated methods. Differences were tested by logistic regression analysis adjusted for age, gender and body mass index (BMI).
RESULTS: No significant differences in craniofacial morphology were found between hEDS patients and controls. Airway minimum cross-sectional area (P = 0.019) and airway volume (P = 0.044) were significantly smaller in hEDS patients compared to controls. When adjusted for age, gender and BMI no significant differences were found. However, minimum cross-sectional area was almost significant (P = 0.077).
CONCLUSIONS: The craniofacial morphology and airway dimensions of hypermobile Ehlers-Danlos syndrome patients were comparable to controls, with a tendency towards a smaller minimum cross-sectional area in the hypermobile Ehlers-Danlos syndrome group. The results may prove valuable for understanding the effect of hypermobile Ehlers-Danlos syndrome on craniofacial morphology and the upper airways.
Copyright © Sonnesen L, Pawlik T, Fejerskov Lauridsen E. Published in the JOURNAL OF ORAL & MAXILLOFACIAL RESEARCH (http://www.ejomr.org), 30 June 2021.

Entities:  

Keywords:  adult; cone-beam computed tomography; face; pharynx; syndrome

Year:  2021        PMID: 34377382      PMCID: PMC8326884          DOI: 10.5037/jomr.2021.12205

Source DB:  PubMed          Journal:  J Oral Maxillofac Res        ISSN: 2029-283X


INTRODUCTION

The Ehlers-Danlos syndrome (EDS) is a group of inherited connective tissue disorders caused by abnormalities in the structure, production and/or processing of collagen [1]. These disorders show considerable clinical and genetic heterogeneity and affect multiple organ systems. Joint hypermobility, dermal extensibility and cutaneous scarring compose the classical triad of the disorder [2]. Due to the vast genetic heterogeneity and phenotypic variability and the clinical overlap between EDS subtypes, but also with other heritable connective tissue disorders, the definite diagnosis of all EDS subtypes, except for the hypermobile type, relies on molecular confirmation with identification of causative genetic variants [1]. The estimated prevalence of EDS is 1/5,000, and the hypermobile EDS (hEDS) subtype is the most frequent [3]. hEDS, which is considered the least severe subtype of EDS, can only be diagnosed clinically and relies on three criteria outlined by the 2017 classification [1,4]. However, genetic testing is used in order to exclude other types of EDS [1]. The upper airway consists of the external nose, internal nose or nasal cavity, paranasal sinuses, the oral cavity and the pharynx [5]. The pharynx is subdivided into the nasopharynx, oropharynx and laryngopharynx and is part of the digestive system and conducting zone of the respiratory system [6,7]. The walls of the pharynx consist of connective tissue and skeletal musculature [6,7] enclosed by bony structures [8]. Upper airway volume and minimum cross-sectional area have not previously been investigated in EDS, but studies have found that obstructive sleep apnea (OSA) is significantly more frequent in EDS compared to controls [9-11]. The small minimum cross-sectional area has been found to be the most relevant anatomical characteristic of the upper airway related to the pathogenesis of OSA [12]. The craniofacial morphology in EDS has seemingly only been reported in studies using clinical assessment or quantitative photographic analysis technique [9,10]. One study using photography found no significant differences in craniofacial morphology in EDS compared to controls [9], whereas a clinical assessment showed that EDS had significant nasal septum deviation with internal valve collapse, high arched palatal vault, micrognathia, tongue scalloping and cross bite [10]. As EDS is a disorder that inflicts the connective tissue, it is reasonable to hypothesize that this may lead to changes in the soft tissue, e.g. upper airway dimensions and/or skeletal morphology of the craniofacial complex in patients with EDS. The aim of the present case-control study was to compare craniofacial morphology and upper airway dimensions between a group of hypermobile Ehlers-Danlos syndrome patients and a healthy control group.

MATERIAL AND METHODS

Subjects The patient group was extracted from a larger group of hEDS patients comprising part of another study (n = 26), which was conducted between August 1st and November 30th 2017 [13]. Inclusion criterion was clinical hEDS diagnosed by a rheumatologist according to the Villefranche classification [14] and differentiated by a genetic test in order to exclude other types of EDS. The genetic test was performed on all hEDS patients and carried out from a saliva sample mixed with residues from a mucosa scrape. The sample was tested for mutations in genes associated with other EDS subtypes: COL3A1, COL5A1, COL5A2, COL1A1, COL1A2, PLOD1 and CHST14 in preparation for confirming and excluding other EDS subtypes than hEDS [1]. Exclusion criteria: (a) incomplete lateral cephalogram or cone-beam computed tomography (CBCT) image and/or (b) compromised imagery of upper airways in three-dimension due to swallowing during execution (Figure 1).
Figure 1

Flow chart.

Flow chart. Thus, the patient group included 18 patients with hEDS (16 females, 2 males, mean age 34.1 (SD 10.35) years). The mean body mass index (BMI) was 26.3 (SD 5.88). The control group was selected from a larger group of healthy controls and comprised students and staff members at the Department of Odontology, University of Copenhagen (n = 39) [13]. Inclusion criteria: No known diseases or syndromes; Neutral craniofacial morphology (sagittal jaw relation: 2° [SD 2.5°]; vertical jaw relation: 25° [SD 6°]) [15]; Neutral occlusion; No history of orthodontic treatment. Exclusion criteria (Figure 1): Incomplete lateral cephalogram or CBCT image; Compromised imagery of upper airways in three-dimension due to swallowing during execution. Thus, 16 individuals (14 females, 2 males, mean age 37.9 [SD 10.87] years) comprised the control group of the present study. The mean BMI was 23.9 (SD 3.52). When power analysis was performed under the assumption that the differences in craniofacial morphology and upper airway dimensions occur in 50% in patients with EDS, at least 16 subjects in each group were required to have sufficient power (80%) in order to identify statistically significant differences at the 5% level of significance. Thus, the sample size was considered sufficient in the present study. The study followed the guidelines of the Declaration of Helsinki and was approved by the Danish National Committee on Health Research Ethics (Protocol H‐17015290) and the Danish Data Protection Agency (SUND‐2017‐28). Methods Lateral cephalograms were obtained in order to assess the craniofacial morphology, and CBCT scans were recorded to assess the dimensions of the upper airway. All were taken at the Cephalometric Laboratory, Department of Odontology, University of Copenhagen. The radiographs and scans were taken after randomization in order to blind the observer to the health status of the individuals. The lateral cephalograms were obtained in a Promax (2D X-ray- Unit - Planmeca OY; Helsinki, Finland, 2012) with a focus to sensor distance of 501 mm, enlargement of 13% and resolution of 183. The CBCT scans were obtained in a Promax (3D Max Sensorhead, sensor type 2520E - Planmeca Oy; Helsinki, 2012) with a focus to sensor distance of 632 and maximum field of view of 230 x 260 mm. All two-dimensional and three-dimensional images were taken in the natural head position as evaluated by mirror [16,17]. For the analysis of the craniofacial morphology, variables in the sagittal and vertical dimensions were used [15]. The sagittal variables were: sagittal jaw relation (ss-n-pg), maxillary prognathia (s-n-ss) and mandibular prognathia (s-n-pg) (Figure 2). The vertical variables were: vertical jaw relation (NL/ML), maxillary inclination (NSL/NL) and mandibular inclination (NSL/ML) (Figure 2). The lateral cephalograms were digitized in Total Interactive Orthodontic Planning System version 4.4.0.0 (Tiops5; Copenhagen, Denmark).
Figure 2

Illustration of points and lines for the craniofacial morphology variables (Björk [15]).

s = sella; n = nasion; ss = subspinale; pg = pogonion; NSL = nasion-sella-line; NL = nasal-line; ML = mandibular-line.

Sagittal variables: sagittal jaw relation (ss-n-pg), maxillary prognathia (s-n-ss), mandibular prognathia (s-n-pg). Vertical variables: vertical jaw relation (NL/ML), maxillary inclination (NSL/NL), mandibular inclination (NSL/ML).

Illustration of points and lines for the craniofacial morphology variables (Björk [15]). s = sella; n = nasion; ss = subspinale; pg = pogonion; NSL = nasion-sella-line; NL = nasal-line; ML = mandibular-line. Sagittal variables: sagittal jaw relation (ss-n-pg), maxillary prognathia (s-n-ss), mandibular prognathia (s-n-pg). Vertical variables: vertical jaw relation (NL/ML), maxillary inclination (NSL/NL), mandibular inclination (NSL/ML). The pharyngeal airway volume and the minimum cross-sectional area (Figure 3) were analysed by Romexis 3D imaging software (Planmeca OY; Helsinki, Finland, 2012) after importing the DICOM images into the program [18,19]. The upper airway margins were manually determined according to previously validated definitions and methods [18,19]. The upper airway margins were outlined in the midsagittal plane. The midsagittal plane was identified as the sagittal slice that includes the anterior nasal spine and incisive canal [18]. The superior border was the nasal floor in the level of the posterior nasal spine. The inferior border was the base of the epiglottis. In the axial plane, it was checked that the pharynx was included in its full extension from top to bottom according to the chosen superior and inferior margins [18,19]. Airway volume was then calculated in the program using the designated tool. Volume was measured in cm3. The minimum cross-sectional area was determined by scrolling from superior to inferior margin in the axial plane until the smallest measurement was encountered [18,19]. The minimum cross-sectional area was measured in mm2.
Figure 3

Illustration of the upper airway volume and cross-sectional area: A = sagittal; B = axial plane.

Airways coloured by area: narrowest passages with the smallest area are highlighted in red.

Illustration of the upper airway volume and cross-sectional area: A = sagittal; B = axial plane. Airways coloured by area: narrowest passages with the smallest area are highlighted in red. Reliability To determine the intra-examiner reliability, a total of 25 randomly chosen lateral cephalograms and corresponding three-dimensional scans were analysed twice within 2 weeks. SPSS software version 26.0 (IBM Inc.; Chicago, Illinois, USA) was used for the data analysis. For the assessment of systematic error, a paired sampled t-test was performed. No systematic error was found. For the evaluation of measurement error and the reliability the Dahlberg formula [20] and the Houston’s reliability coefficient [21] were used, respectively. The method error for the craniofacial morphology ranged between 0.003° and 0.015°, for the upper airway volume 0.016 cm3 and minimum cross-sectional area 0.5 mm2. The reliability coefficient for both the craniofacial morphology and the upper airway dimensions was 1. Statistical analysis Statistical Analysis Software (SAS) version 9.4 (Cary, N.C., USA) and IBM SPSS Statistics Version 26 (IBM Inc. Chicago, Illinois, USA) was used for the statistical analysis. Parametric data were expressed as mean and standard deviation (M [SD]) and the statistical significance level was defined at P < 0.05. The distribution of the data was assessed by Quantile-Quantile plots (Q-Q-plots). The data was normally distributed. The difference in distribution of gender was assessed by Fisher’s exact test. Age and BMI differences between the two groups were tested by an independent t-test. Differences in craniofacial morphology and airway dimensions between the two groups were investigated by logistic regression. The first analysis was univariate with each covariate as the explanatory variable and hEDS/control as the dependent variable. Model validation was performed using residuals and tests for goodness of fit. The second analysis was similar to the first, though adjusted for age, gender and BMI. The primary statistical analysis included logistic regression analysis modelling the probability for hEDS. Results were presented by odds ratios (OR) with 95% confidence limits and the concordance statistic or C-statistic/area under the curve.

RESULTS

There was no significant difference in gender, age or BMI distribution between the two groups (P-value > 0.05 respectively). Regarding the skeletal craniofacial morphology in the sagittal and vertical plane, no statistically significant differences were shown between the two groups (P-value > 0.05 respectively, Table 1 and 2). Regarding the incisal relationship in terms of overjet and overbite, no statistically significant differences were found between the groups (P-value > 0.05 respectively, Table 1 and 2).
Table 1

Differences between the groups

Marker Odds ratio OR lower CL OR upper CL P-value AUC Mean difference (control - hEDS)
Airway dimensions

Volume (cm3) 0.85 0.72 1 0.044a 0.7 3.8

Min. cross-sectional area (mm2) 0.99 0.97 1 0.019a 0.75 67.1

Craniofacial morphology

ss-n-pg (degrees) 1.03 0.72 1.46 0.871 0.51 -0.1

s-n-ss (degrees) 0.97 0.79 1.18 0.755 0.55 0.4

s-n-pg (degrees) 0.97 0.8 1.17 0.717 0.52 0.5

NL/ML (degrees) 0.93 0.8 1.06 0.277 0.63 1.9

NSL/NL (degress) 1.15 0.92 1.44 0.231 0.62 -1.3

NSL/ML (degrees) 0.98 0.87 1.1 0.745 0.58 0.6

Incisal relations

Overjet (mm) 1.31 0.69 2.51 0.409 0.55 -0.3

Overbite (mm) 1.09 0.62 1.92 0.764 0.57 -0.1

aStatistically significant at level P < 0.05 (Paired samples t-test).

OR = odds ratio; CL = confidence level; AUC = area under the curve; ss-n-pg = sagittal jaw relation; s-n-ss = maxillary prognathia; s-n-pg = mandibular prognathia; NL/ML = vertical jaw relation; NSL/NL = maxillary inclination; NSL/ML = mandibular inclination.

Table 2

Difference between the two groups adjusted for age, gender and body mass index (BMI)

Marker Variable Odds ratio OR lower CL OR upper CL P-value AUC
Airway dimensions
Volume Age 0.96 0.89 1.05 0.381 0.73
 
BMI 1.1 0.92 1.32 0.301

Gender 1.89 0.12 29.84 0.65

Marker 0.89 0.74 1.06 0.188

Cross sectional area Age 0.97 0.89 1.05 0.428 0.76

BMI 1.07 0.88 1.3 0.5

Gender 1.63 0.1 26.42 0.731

Marker 0.99 0.97 1 0.077

Craniofacial morphology
ss-n-pg Age 0.95 0.88 1.02 0.174 0.69

BMI 1.16 0.98 1.37 0.091

Gender 3.66 0.27 50 0.331

Marker 1.02 0.68 1.52 0.935







s-n-ss Age 0.95 0.88 1.02 0.177 0.67

BMI 1.16 0.98 1.37 0.085

Gender 4.27 0.33 56.06 0.269

Marker 0.95 0.77 1.19 0.672







s-n-pg Age 0.95 0.88 1.02 0.171 0.68

BMI 1.16 0.98 1.37 0.088

Gender 3.89 0.32 47.59 0.288

Marker 0.96 0.78 1.17 0.685







NL/ML Age 0.94 0.87 1.02 0.154 0.69

BMI 1.15 0.97 1.37 0.108

Gender 3.49 0.28 44.27 0.334

Marker 0.93 0.79 1.08 0.324







NSL/NL Age 0.95 0.88 1.02 0.167 0.69

BMI 1.15 0.97 1.36 0.12

Gender 3.63 0.29 45.29 0.316

Marker 1.13 0.88 1.45 0.33







NSL/ML Age 0.95 0.88 1.02 0.17 0.69

BMI 1.16 0.98 1.37 0.088

Gender 3.72 0.3 45.67 0.304

Marker 0.98 0.86 1.11 0.734
Incisal relations
Overjet Age 0.93 0.85 1.01 0.089 0.74

BMI 1.18 0.99 1.4 0.067

Gender 4.57 0.35 59.52 0.246

Marker 1.64 0.82 3.3 0.163

Overbite Age 0.94 0.86 1.02 0.12 0.72

BMI 1.18 0.99 1.4 0.072

Gender 4.79 0.35 65.77 0.241

Marker 1.37 0.7 2.69 0.354

Differences were tested by logistic regression analysis adjusted for age, gender and body mass index (BMI).

OR = odds ratio; CL = confidence level; AUC = area under the curve; ss-n-pg = sagittal jaw relation; s-n-ss = maxillary prognathia; s-n-pg = mandibular prognathia; NL/ML = vertical jaw relation; NSL/NL = maxillary inclination; NSL/ML = mandibular inclination.

Differences between the groups aStatistically significant at level P < 0.05 (Paired samples t-test). OR = odds ratio; CL = confidence level; AUC = area under the curve; ss-n-pg = sagittal jaw relation; s-n-ss = maxillary prognathia; s-n-pg = mandibular prognathia; NL/ML = vertical jaw relation; NSL/NL = maxillary inclination; NSL/ML = mandibular inclination. Airway dimensions expressed as volume (P-value 0.044, OR = 0.85 [0.72; 1]) and minimum cross-sectional area (P-value 0.019, OR = 0.99 [0.97; 1]) were statistically significant with hEDS having significantly smaller airway dimensions than controls (Table 1). When the airway volume and minimum cross-sectional area were adjusted for gender, age and BMI, no statistically significant difference was found between the groups (P-value > 0.05 respectively, Table 2). However, minimum cross-sectional area was almost significant with a P-value of 0.077, OR = 0.99 (0.97; 1) (Table 2). Difference between the two groups adjusted for age, gender and body mass index (BMI) Differences were tested by logistic regression analysis adjusted for age, gender and body mass index (BMI). OR = odds ratio; CL = confidence level; AUC = area under the curve; ss-n-pg = sagittal jaw relation; s-n-ss = maxillary prognathia; s-n-pg = mandibular prognathia; NL/ML = vertical jaw relation; NSL/NL = maxillary inclination; NSL/ML = mandibular inclination.

DISCUSSION

The aims of the present study were to investigate differences in craniofacial morphology assessed on lateral cephalograms and airway dimensions assessed on CBCTs between a group of patients with hEDS and a group of healthy controls. This has not previously been investigated in hEDS. The hEDS group was not only clinically diagnosed by an experienced specialist but also tested genetically in order to exclude other EDS subtypes, i.e. extremely well-diagnosed [13]. Previous studies have pooled mixed EDS subgroups such as hEDS, clEDS and others [9,10]. The control group in the present study comprised healthy individuals with neutral occlusion and normal craniofacial morphology, which is important for an investigation of the upper airway. Previous studies have found that changes in the upper airway are associated with malocclusion and deviations of the craniofacial morphology such as e.g. a posterior position of the mandible [22-26]. Even though the sample sizes in the hEDS as well as in the control groups in the present study were relatively small, the power analysis showed sufficient power. Still, the sample size may influence the confidence limits of OR. In the present study, the upper airway dimensions were assessed on CBCT obtained in the natural head position as evaluated by mirror [16,17]. For the assessment of the upper airway it is important that the individual is scanned in the natural head position as it has been shown that head posture has an influence on upper airway dimensions [19,27]. Airway dimensions are not static, but influenced by the dynamics of variables such as head posture, state of respiration and mobility of the soft tissues [28-32]. It has been shown on CBCT that an extended head posture is associated with greater airway dimensions and cross sectional area in the level of the os hyoideum, but not with airway volume [19]. In the present study, no statistically significant differences in craniofacial morphology were seen between the two groups. This is in agreement with a previous study, even though that study included a mixed patient group with various subtypes of EDS and a quantitative photographic analysis technique was used to assess the craniofacial morphology [9]. Another study clinically assessed the craniofacial morphology on EDS patients; a morphological analysis of the craniofacial morphology was not included nor was a control group [10]. In that study, the facial structures of the EDS patients were reported to include nasal septum deviation, high arched palatal vault and retrognathia of the jaws [10]. The majority of the EDS patients also had existing complaints of fatigue and poor sleep, so they may have had a craniofacial morphology predisposing to sleep disordered breathing (SDB) and thus may not be representative of the general EDS population. An explanation for the lack of difference in craniofacial morphology between the hEDS group and the control group in the present study could be that the connective tissue abnormalities particular to hEDS did not have a detectable impact on the craniofacial structures. Furthermore, craniofacial morphology is dependent on many factors including skeletal, soft tissue and function. Hence, craniofacial morphology is a complex entity and most likely more than the sum of the individual parts [27,33-37]. In the present study, the upper airway dimensions were significantly smaller in the hEDS group compared to the control group. When adjusted for age, gender and BMI, the difference was no longer significant, although the minimum cross-sectional area was almost significant. An explanation could be that as there was no difference in craniofacial morphology between the hEDS group and the control group, there was also no difference in upper airway dimensions. Furthermore, the connective tissue abnormality in hEDS may not affect the upper airway dimensions, although the minimum cross-sectional area was almost significant when adjusting for age, gender and BMI. This, however, suggested an impact of hEDS on the upper airway dimensions. It is well known that the upper airways are influenced by age, gender and BMI. Therefore, it is important to adjust for age, gender and BMI in the statistical analysis as was the case in the present study. The size of the upper airway decreases with increasing age in both men and women [38], and sexual dimorphism can be observed in respect to size of the pharynx - men having larger airways than women [39]. Obesity measured as BMI is listed as a predisposition for SDB such as OSA [40]. It was found that body weight, BMI and neck circumference was significantly greater in male patients with SDB compared to a normal control group [8]. Furthermore, studies have shown that BMI was related to mandibular advancement device treatment outcome in OSA [41,42]. Therefore, it may not be surprising that when the results for upper airway volume and minimum cross-sectional area were adjusted for age, gender and BMI, they were no longer statistically significant. However, minimum cross-sectional area was almost significant with a P-value of 0.077. This may suggest an impact of hEDS on the upper airway dimensions and that patients with hEDS may be more susceptible to obstruction of the upper airway.

CONCLUSIONS

Craniofacial morphology and airway dimensions of patients with hypermobile Ehlers-Danlos syndrome were comparable to those in healthy controls when adjusted for age, gender and body mass index with a tendency towards a smaller minimum cross-sectional area in the hypermobile Ehlers-Danlos syndrome group. The results of the present study may prove valuable in the understanding of the effect of hypermobile Ehlers-Danlos syndrome on craniofacial morphology and the upper airway and may indicate a tendency towards an impact of the underlying connective tissue disorder on the upper airway dimensions.
  37 in total

Review 1.  Obstructive sleep apnoea.

Authors:  Atul Malhotra; David P White
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321

2.  Influence of craniofacial and upper spine morphology on mandibular advancement device treatment outcome in patients with obstructive sleep apnoea: a pilot study.

Authors:  Palle Svanholt; Niels Petri; Gordon Wildschiødtz; Liselotte Sonnesen
Journal:  Eur J Orthod       Date:  2014-10-28       Impact factor: 3.075

3.  Establishment and baseline characteristics of a nationwide Danish cohort of patients with Ehlers-Danlos syndrome.

Authors:  Marie-Louise Kulas Søborg; Julie Leganger; Laura Quitzau Mortensen; Jacob Rosenberg; Jakob Burcharth
Journal:  Rheumatology (Oxford)       Date:  2017-05-01       Impact factor: 7.580

4.  Effects of a fixed functional appliance on upper airway volume: A 3-dimensional cone-beam computed tomography study.

Authors:  Yousef Abdalla; Louise Brown; Liselotte Sonnesen
Journal:  Am J Orthod Dentofacial Orthop       Date:  2020-05-07       Impact factor: 2.650

5.  The analysis of errors in orthodontic measurements.

Authors:  W J Houston
Journal:  Am J Orthod       Date:  1983-05

6.  Obstructive sleep apnoea and quality of life in Ehlers-Danlos syndrome: a parallel cohort study.

Authors:  Thomas Gaisl; Cecilia Giunta; Daniel J Bratton; Kate Sutherland; Christian Schlatzer; Noriane Sievi; Daniel Franzen; Peter A Cistulli; Marianne Rohrbach; Malcolm Kohler
Journal:  Thorax       Date:  2017-01-10       Impact factor: 9.139

Review 7.  Three-dimensional imaging of the upper airway anatomy in obstructive sleep apnea: a systematic review.

Authors:  Hui Chen; Ghizlane Aarab; Maurits H T de Ruiter; Jan de Lange; Frank Lobbezoo; Paul F van der Stelt
Journal:  Sleep Med       Date:  2016-04-05       Impact factor: 3.492

8.  Sleep-disordered breathing in Ehlers-Danlos syndrome: a genetic model of OSA.

Authors:  Christian Guilleminault; Michelle Primeau; Hsiao-Yean Chiu; Kin Min Yuen; Damien Leger; Arnaud Metlaine
Journal:  Chest       Date:  2013-11       Impact factor: 9.410

9.  Airway adequacy, head posture, and craniofacial morphology.

Authors:  B Solow; S Siersbaek-Nielsen; E Greve
Journal:  Am J Orthod       Date:  1984-09

10.  Updates in Clinical and Genetics Aspects of Hypermobile Ehlers Danlos Syndrome

Authors:  Irman Forghani
Journal:  Balkan Med J       Date:  2018-07-31       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.